Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan S Bellack

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Life Sciences|August 28, 2003
Modulation of MK-801-elicited mouse popping behavior by galantamine is complex and dose-dependentStephen I Deutsch, Richard B Rosse, Eddie N Billingslea, et al.
Pharmacology, Biochemistry, and Behavior|December 14, 2002
Interaction of stress and strain on glutamatergic neurotransmission: relevance to schizophreniaEddie N Billingslea, John Mastropaolo, Richard B Rosse, et al.
Archives of General Psychiatry|April 6, 2006
A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illnessAlan S Bellack, Melanie E Bennett, Jean S Gearon, et al.
European Journal of Pharmacology|August 7, 2002
Topiramate antagonizes MK-801 in an animal model of schizophreniaStephen I Deutsch, Richard B Rosse, Eddie N Billingslea, et al.
Clinical Neuropharmacology|April 3, 2003
Methyllycaconitine fails to inhibit electrically precipitated tonic hindlimb extension in miceStephen I Deutsch, Richard B Rosse, Alan S Bellack, et al.
The American Journal of Drug and Alcohol Abuse|February 26, 2010
Examination of the inventory of drug use consequences with individuals with serious and persistent mental illness and co-occurring substance use disordersMelanie E Bennett, Melissa Nidecker, Joanna E Strong Kinnaman, et al.
Psychiatric Services (Washington, D.C.)|January 10, 2012
Assessing recovery of people with serious mental illness: development of a new scaleAmy L Drapalski, Deborah Medoff, George J Unick, et al.
The American Journal of Psychiatry|February 3, 2004
Do clozapine and risperidone affect social competence and problem solving?Alan S Bellack, Nina R Schooler, Stephen R Marder, et al.
The American Journal of Psychiatry|December 17, 2009
A randomized, controlled trial of computer-assisted cognitive remediation for schizophreniaDwight Dickinson, Wendy Tenhula, Sarah Morris, et al.
Schizophrenia Bulletin|December 4, 2009
The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statementsLisa B Dixon, Faith Dickerson, Alan S Bellack, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Life Sciences|August 28, 2003
Modulation of MK-801-elicited mouse popping behavior by galantamine is complex and dose-dependentStephen I Deutsch, Richard B Rosse, Eddie N Billingslea, et al.
Pharmacology, Biochemistry, and Behavior|December 14, 2002
Interaction of stress and strain on glutamatergic neurotransmission: relevance to schizophreniaEddie N Billingslea, John Mastropaolo, Richard B Rosse, et al.
Archives of General Psychiatry|April 6, 2006
A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illnessAlan S Bellack, Melanie E Bennett, Jean S Gearon, et al.
European Journal of Pharmacology|August 7, 2002
Topiramate antagonizes MK-801 in an animal model of schizophreniaStephen I Deutsch, Richard B Rosse, Eddie N Billingslea, et al.
Clinical Neuropharmacology|April 3, 2003
Methyllycaconitine fails to inhibit electrically precipitated tonic hindlimb extension in miceStephen I Deutsch, Richard B Rosse, Alan S Bellack, et al.
The American Journal of Drug and Alcohol Abuse|February 26, 2010
Examination of the inventory of drug use consequences with individuals with serious and persistent mental illness and co-occurring substance use disordersMelanie E Bennett, Melissa Nidecker, Joanna E Strong Kinnaman, et al.
Psychiatric Services (Washington, D.C.)|January 10, 2012
Assessing recovery of people with serious mental illness: development of a new scaleAmy L Drapalski, Deborah Medoff, George J Unick, et al.
The American Journal of Psychiatry|February 3, 2004
Do clozapine and risperidone affect social competence and problem solving?Alan S Bellack, Nina R Schooler, Stephen R Marder, et al.
The American Journal of Psychiatry|December 17, 2009
A randomized, controlled trial of computer-assisted cognitive remediation for schizophreniaDwight Dickinson, Wendy Tenhula, Sarah Morris, et al.
Schizophrenia Bulletin|December 4, 2009
The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statementsLisa B Dixon, Faith Dickerson, Alan S Bellack, et al.
Pageof 5